Our portfolio

TrianecT

TrianecT develops StrokePointer, a portable EEG device that detects stroke severity in ambulances. The technology combines brain activity measurement through a proprietary headset with AI to diagnose Large Vessel Occlusion (LVO) strokes. Detection of an LVO stroke in the ambulance will allow patients to be immediately transported to a stroke center for timely treatment, to drastically improve the patient outcomes.

Industry: Diagnostics, Medical Technology, Stroke

Want to get in contact about TrianecT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Providing quantum-safe security solutions to protect organizations from future cyber threats.
Engineering antibodies to treat neurodegenerative and immune diseases.
AI-driven stroke treatment modeling for thrombectomy device development.
Modulating immune responses with glycan-modified antigens for autoimmune and oncology treatments.
Providing quantum-safe security solutions to protect organizations from future cyber threats.
Engineering antibodies to treat neurodegenerative and immune diseases.
AI-driven stroke treatment modeling for thrombectomy device development.
Modulating immune responses with glycan-modified antigens for autoimmune and oncology treatments.